A recent businesswire article discussed the latest product to receive the FDA’s coveted emergency use authorization. The Detect COVID-19 test from Detect™, Inc. will be available for over-the-counter home use in the coming weeks. The cost will be under $50, which makes it the lowest priced at-home molecular test available to consumers. The test will also be used for regular screening programs in school and workplaces.
OTC COVID-19 Test Gets FDA Emergency Use Authorization
The DETECT™ test will be the lowest priced PCR-quality test available for use at home.
Nov 5, 2021
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More